Similar articles

• Fine specificity of class I MHC recognition in islet allografts.

  Ferguson D, Kohli N, Munn SR. Ferguson D, et al. Transplant Proc. 1995 Dec;27(6):3222. Transplant Proc. 1995. PMID: 8539924 No abstract available.
• Role of intra-islet endothelial cells in islet allo-immunity.

  Bharat A, Saini D, Benshoff N, Goodman J, Desai NM, Chapman WC, Mohanakumar T. Bharat A, et al. Transplantation. 2007 Nov 27;84(10):1316-23. doi: 10.1097/01.tp.0000288192.11396.70. Transplantation. 2007. PMID: 18049117
• Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.

  Lee MK 4th, Huang X, Jarrett BP, Moore DJ, Desai NM, Moh Lian M, Markmann JW, Deng S, Frank A, Singer A, Velidedeoglu E, Caton AJ, Markmann AJ. Lee MK 4th, et al. Transplantation. 2003 Apr 27;75(8):1415-22. doi: 10.1097/01.TP.0000064296.65628.6C. Transplantation. 2003. PMID: 12717241
• The contribution of MHC antigen modulation to islet allograft rejection.

  Markmann JF, Schachner MS, Bassiri H, Barker CF, Naji A. Markmann JF, et al. Horm Metab Res Suppl. 1990;25:104-8. Horm Metab Res Suppl. 1990. PMID: 2088947 Review. No abstract available.
• Manipulation of pancreatic islet cells in allotransplantation.

  Tze WJ, Tai J. Tze WJ, et al. Transplant Proc. 1982 Dec;14(4):714-23. Transplant Proc. 1982. PMID: 6820204 Review. No abstract available.